Shelter Pharma Ltd
Incorporated in 2007, Shelter Pharma Ltd manufactures pharma products including
food supplements for animals[1]
- Market Cap ₹ Cr.
- Current Price ₹
- High / Low ₹ /
- Stock P/E
- Book Value ₹
- Dividend Yield %
- ROCE %
- ROE %
- Face Value ₹
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals
Quarterly Results
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Dividend Payout % |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Figures in Rs. Crores
| Equity Capital |
| Reserves |
| Total Liabilities |
| CWIP |
| Investments |
| Total Assets |
Cash Flows
Figures in Rs. Crores
| Net Cash Flow |
Ratios
Figures in Rs. Crores
| Debtor Days |
| Inventory Days |
| Days Payable |
| Cash Conversion Cycle |
| Working Capital Days |
| ROCE % |
Documents
Announcements
-
Non-Applicability Of Regulation 23(9) As Per Regulation 15 Of Chapter IV Of SEBI (LODR) Regulations, 2015 For The Half Year And Year Ended March 2025.
29 May - Shelter Pharma certifies non-applicability of related party transaction reporting for FY 2025 as SME listed company.
-
Intimation Under Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015 Regarding Appointment Of CA Ismail Ibrahimbhai Lakhani (M/S. I I LAKHANI & CO), FRN NO: 143750W Chartered Accountants As Internal Auditor
29 May - Appointment of CA Ismail Ibrahimbhai Lakhani as internal auditor for FY 2025-26.
-
Intimation Under Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015 Regarding Reappointment Of M/S. Murtuza Mandorwala & Associates As Secretarial Auditor For The Period Of 5 Years
29 May - Reappointment of secretarial auditor M/s. Murtuza Mandorwala & Associates for five years from 2025-26 to 2029-30.
-
Submission Of The Audited Standalone Financial Results For The Half Year And Year Ended March 31, 2025
29 May - Shelter Pharma reports FY25 audited results with Rs 967.7L profit; appoints internal and secretarial auditors.
-
Board Meeting Outcome for Outcome Of The Board Meeting And Submission Of The Audited Standalone Financial Results For The Half Year And Year Ended March 31, 2025
29 May - Audited FY25 standalone results approved; internal and secretarial auditors appointed for FY26 onwards.
Business Overview:[1]
SPL is a GMP & HACCP certified and ISO 9001:2015 certified manufacturer and seller of a range of herbal Ayurvedic medicines in India for humans and food supplements for animals